TY - JOUR
T1 - Reduction of fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system
AU - Rotter, Martin
AU - Takahashi, Yoshihide
AU - Sanders, Prashanthan
AU - Haïssaguerre, Michel
AU - Jaïs, Pierre
AU - Hsu, Li Fern
AU - Sacher, Fréderic
AU - Pasquié, Jean Luc
AU - Clementy, Jacques
AU - Hocini, Mélèze
N1 - Funding Information:
M.R. is supported by the Swiss National Foundation for Scientific Research, Bern, Switzerland. P.S. is supported by the Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council of Australia and the Ralph Reader Fellowship from the National Heart Foundation of Australia.
PY - 2005/7
Y1 - 2005/7
N2 - Aims: Catheter ablation of atrial fibrillation (AF) is centred on pulmonary vein (PV) ablation with or without additional atrial substrate modification. These procedures may be prolonged with significant fluoroscopy exposure. This study evaluates a new non-fluoroscopic navigation system during ablation of AF. Methods and results: Seventy-two patients undergoing catheter ablation of symptomatic drug refractory AF were prospectively randomized to ablation with (n = 35; study group) or without (n = 37; control group) non-fluoroscopic navigation. PV isolation was performed in all patients. In patients with persistent or inducible sustained AF after PV isolation linear ablation was performed by joining the superior PVs. PV isolation was achieved in all patients; fluoroscopy (15.4 ± 3.4 vs. 21.3 ± 6.4 min; P < 0.001) and procedural (52 ± 12 vs. 61 ± 17 min; P = 0.02) durations were significantly reduced in the study group. Linear block was achieved in 37 of the 39 patients; with a significant reduction in fluoroscopy (5.6 ± 2.2 vs. 9.9 ± 4.8 min; P = 0.003) and procedural (14.7 ± 5.5 vs. 26.6 ± 16.9 min; P = 0.007) durations in the study group. After a follow-up of 6.9 ± 2.9 months (range 3-10), 26 (74%) patients in the non-fluoroscopic navigation group and 29 (78%) patients in the control group were arrhythmia-free after the first procedure. Conclusion: This prospectively randomized study demonstrates significant reduction of fluoroscopy exposure and procedural duration using supplementary non-fluoroscopic imaging system for AF ablation.
AB - Aims: Catheter ablation of atrial fibrillation (AF) is centred on pulmonary vein (PV) ablation with or without additional atrial substrate modification. These procedures may be prolonged with significant fluoroscopy exposure. This study evaluates a new non-fluoroscopic navigation system during ablation of AF. Methods and results: Seventy-two patients undergoing catheter ablation of symptomatic drug refractory AF were prospectively randomized to ablation with (n = 35; study group) or without (n = 37; control group) non-fluoroscopic navigation. PV isolation was performed in all patients. In patients with persistent or inducible sustained AF after PV isolation linear ablation was performed by joining the superior PVs. PV isolation was achieved in all patients; fluoroscopy (15.4 ± 3.4 vs. 21.3 ± 6.4 min; P < 0.001) and procedural (52 ± 12 vs. 61 ± 17 min; P = 0.02) durations were significantly reduced in the study group. Linear block was achieved in 37 of the 39 patients; with a significant reduction in fluoroscopy (5.6 ± 2.2 vs. 9.9 ± 4.8 min; P = 0.003) and procedural (14.7 ± 5.5 vs. 26.6 ± 16.9 min; P = 0.007) durations in the study group. After a follow-up of 6.9 ± 2.9 months (range 3-10), 26 (74%) patients in the non-fluoroscopic navigation group and 29 (78%) patients in the control group were arrhythmia-free after the first procedure. Conclusion: This prospectively randomized study demonstrates significant reduction of fluoroscopy exposure and procedural duration using supplementary non-fluoroscopic imaging system for AF ablation.
KW - Atrial fibrillation
KW - Linear ablation
KW - Non-fluoroscopic imaging
KW - Pulmonary vein isolation
UR - http://www.scopus.com/inward/record.url?scp=22944439488&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehi172
DO - 10.1093/eurheartj/ehi172
M3 - Article
C2 - 15741228
AN - SCOPUS:22944439488
SN - 0195-668X
VL - 26
SP - 1415
EP - 1421
JO - European heart journal
JF - European heart journal
IS - 14
ER -